Benzinga
12 May 2026, 17:59 UTC · 21w ago
Investors Await Damage Assessment After West Pharmaceutical Cyberattack
Impact · against what's priced in
West Pharmaceutical Services faces immediate operational and financial uncertainty following a material cyberattack involving data exfiltration and system encryption. While the company's franchise status remains strong, the lack of a recovery timeline and unquantified financial impact create an open-ended risk for the stock.
- WST−0.50
No priced-in read yet
- In context
The material cybersecurity attack on May 7 disrupted global operations and resulted in data exfiltration, with some sites still awaiting full restoration and the total financial impact remaining undetermined.
Read from the article alone
Search tags
